Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug Delivery: Enteral Route

Drug Delivery: Enteral Route

The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
Drugs in...

Administering Oxygen by Nasal Cannula

Administering Oxygen by Nasal Cannula

Oxygen therapy is critical to patient care, especially for those struggling with respiratory issues. This intervention increases the oxygen concentration in the lungs, enhancing the amount of oxygen transported to the body's tissues. One standard method of delivering supplemental oxygen is through a nasal cannula, a non-invasive device that provides low to medium oxygen concentrations.
Nasal Cannulas
A nasal cannula is a lightweight tube split into two prongs placed in the nostrils, connected...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Advances in the Management of Persistent Pulmonary Hypertension of the Newborn.

Clinics in perinatology·2026

Same authorSame journal

Breathing Physiology into the Art of Neonatal Respiratory Care.

Clinics in perinatology·2026

Same author

Impaired Taurine Transport Contributes to Bronchopulmonary Dysplasia: A Systems Biology Analysis.

American journal of respiratory cell and molecular biology·2026

Same author

Pediatric Pulmonary Hypertension is Associated With Increased Circulating Levels of BMP 7 and CHIP.

Pulmonary circulation·2025

Same author

Identifying barriers and facilitators to care for infants with bronchopulmonary dysplasia after NICU discharge: a prospective study of parents and clinical stakeholders.

Journal of perinatology : official journal of the California Perinatal Association·2024

Same author

Cellular Senescence Contributes to the Progression of Hyperoxic Bronchopulmonary Dysplasia.

American journal of respiratory cell and molecular biology·2023

Search research articles

Related Experiment Video

Updated: Jun 26, 2026

A Novel Inhalation Mask System to Deliver High Concentrations of Nitric Oxide Gas in Spontaneously Breathing Subjects

A Novel Inhalation Mask System to Deliver High Concentrations of Nitric Oxide Gas in Spontaneously Breathing Subjects

Published on: May 4, 2021

Inhaled nitric oxide for preterm neonates.

Nandini Arul¹, G Ganesh Konduri

¹Division of Neonatology, Medical College of Wisconsin, Milwaukee, WI, USA. narul08@gmail.com

Clinics in Perinatology

|January 24, 2009

Summary

Inhaled nitric oxide (iNO) shows potential benefits for preterm neonates, but its effectiveness in preventing chronic lung disease and brain injury remains inconclusive, warranting further research.

Area of Science:

Neonatology
Pulmonology
Neuroscience

Background:

Inhaled nitric oxide (iNO) has demonstrated benefits in gas exchange, inflammation, and vascular dysfunction in various studies.
Its application in extremely low birth weight neonates for preventing chronic lung disease and neurologic injury is under investigation.
Current findings on iNO's efficacy in this vulnerable population are inconclusive.

Purpose of the Study:

To review the biologic rationale for using iNO in preterm neonates.
To summarize outcomes of recent clinical trials regarding bronchopulmonary dysplasia and brain injury.
To discuss potential toxicities, controversies, and unanswered questions surrounding iNO use in high-risk neonates.

Main Methods:

Review of existing animal and human studies on iNO.

More Related Videos

Preoxygenation Techniques for Tracheal Intubation in Critically Ill Adults Utilizing Oxygen Mask and Noninvasive Ventilation

Preoxygenation Techniques for Tracheal Intubation in Critically Ill Adults Utilizing Oxygen Mask and Noninvasive Ventilation

Published on: December 5, 2025

Intratracheal Instillation of Stem Cells in Term Neonatal Rats

Intratracheal Instillation of Stem Cells in Term Neonatal Rats

Published on: May 4, 2020

Related Experiment Videos

Last Updated: Jun 26, 2026

A Novel Inhalation Mask System to Deliver High Concentrations of Nitric Oxide Gas in Spontaneously Breathing Subjects

A Novel Inhalation Mask System to Deliver High Concentrations of Nitric Oxide Gas in Spontaneously Breathing Subjects

Published on: May 4, 2021

Preoxygenation Techniques for Tracheal Intubation in Critically Ill Adults Utilizing Oxygen Mask and Noninvasive Ventilation

Preoxygenation Techniques for Tracheal Intubation in Critically Ill Adults Utilizing Oxygen Mask and Noninvasive Ventilation

Published on: December 5, 2025

Intratracheal Instillation of Stem Cells in Term Neonatal Rats

Intratracheal Instillation of Stem Cells in Term Neonatal Rats

Published on: May 4, 2020

Analysis of recent clinical trial data on preterm neonates.

Focus on specific outcomes: bronchopulmonary dysplasia and brain injury.

Main Results:

Evidence supports iNO's benefits on gas exchange, inflammation, and vascular dysfunction.
Clinical trial results for preventing chronic lung disease and neurologic injury in preterm neonates are inconclusive.
Potential toxicities and controversies associated with iNO treatment exist.

Conclusions:

The use of iNO in preterm neonates requires careful consideration due to inconclusive evidence on major outcomes.
Further research is needed to address persistent controversies and unanswered questions regarding iNO's safety and efficacy.
Understanding potential toxicities is crucial for optimizing iNO therapy in high-risk neonates.